Lea en español

Granuflo is a powdered concentrate (in its liquid form, it’s known as NaturaLyte) used in dialysis to neutralize excess acid that accumulates when kidneys can no longer filter the acid out of the blood. Granuflo was first approved for sale in the United States in 2003.
During the dialysis process, Granuflo causes a chemical reaction in the liver, converting acidic substances into bicarbonates. Excessive bicarbonate in your blood can be extremely dangerous, leading to sudden and massive heart failure. Evidence indicates that Frenesius Medical Care, the company that markets both Granuflo and NaturaLyte, disseminated an internal memo in 2011, indicating that company official knew of the link to increased risk of stroke and heart attack in users. The evidence also indicates that the company only notified its own dialysis centers of this information.
If you or someone you love has suffered injury after taking Granufo, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics